Trial Profile
A Single-centre Study to Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of a New Inhaled Formulation of AVONEX (Interferon Beta-1a) in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Interferon beta-1a (Primary) ; Interferon beta-1a
- Indications Multiple sclerosis; Ulcerative colitis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Trio Medicines
- 28 Apr 2015 New trial record